Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an...

von Duska, Linda R., Java, James J., Cohn, David E., Burger, Robert A.
Veröffentlicht in Gynecol Oncol (2015)

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2

von Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.
Veröffentlicht in Int J Gynecol Cancer (2017)

Mixed-methods content and sentiment analysis of adolescents’ voice-diaries describing daily experiences with asthma and self-management decision-making

von Mammen, Jennifer R., Java, James J., Rhee, Hyekyun, Butz, Arlene M., Halterman, Jill S., Arcoleo, Kimberly
Veröffentlicht in Clin Exp Allergy (2018)

Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-base...

von Rose, Peter G, Java, James J, Whitney, Charles W., Stehman, Frederick B, Lanciano, Rachelle, Thomas, Gillian M
Veröffentlicht in Gynecol Oncol (2014)

The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group tr...

von Chan, John K., Java, James J., Fuh, Katherine, Monk, Bradley J., Kapp, Daniel S., Herzog, Thomas, Bell, Jeffrey, Young, Robert
Veröffentlicht in Gynecol Oncol (2016)

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

von Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Veröffentlicht in J Clin Oncol (2015)

Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Grou...

von Rose, Peter G., Java, James J., Morgan, Mark A., Secord, Angeles Alvarez, Kesterson, Joshua P., Stehman, Frederick B., Warshal, David P., Creasman, William T., Hanjani, Parviz, Morris, Robert T., Copeland, Larry J.
Veröffentlicht in Gynecol Oncol (2016)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

von Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Veröffentlicht in Gynecol Oncol (2015)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

von Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Veröffentlicht in Br J Cancer (2018)

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group...

von Garcia-Soto, Arlene E, Java, James J, Neira, Wilberto Nieves, Pearson, J Matthew, Cohn, David E., Lele, Shashikant B, Tewari, Krishnansu S, Walker, Joan L, Secord, Angeles Alvarez, Armstrong, Deborah K, Copeland, Larry J
Veröffentlicht in Gynecol Oncol (2016)

Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud...

von Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Veröffentlicht in Gynecol Oncol (2018)

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc...

von Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Veröffentlicht in Gynecol Oncol (2018)

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data...

von Moore, Kathleen N., Java, James J., Slaughter, Katrina N., Rose, Peter G., Lanciano, Rachelle, DiSilvestro, Paul A., Thigpen, J. Tate, Lee, Yi-Chun, Tewari, Krishnansu S., Chino, Junzo, Seward, Shelly M., Miller, David S., Salani, Ritu, Moore, David H., Stehman, Frederick B.
Veröffentlicht in Gynecol Oncol (2016)

Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study

von Bishop, Erin A., Java, James J., Moore, Kathleen N., Spirtos, Nick M, Pearl, Michael L, Zivanovic, Oliver, Kushner, David M, Backes, Floor, Hamilton, Chad A., Geller, Melissa A., Hurteau, Jean, Mathews, Cara, Wenham, Robert M., Ramirez, Pedro T., Zweizig, Susan, Walker, Joan L.
Veröffentlicht in Am J Obstet Gynecol (2017)

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients()

von Fuh, Katherine C., Java, James J., Chan, John K., Kapp, Daniel S., Monk, Bradley J., Burger, Robert A., Young, Robert C., Alberts, David S., McGuire, William P., Markman, Maurie, Bell, Jeffrey, Ozols, Robert F., Armstrong, Deborah K., Aghajanian, Carol, Bookman, Michael A., Mannel, Robert S.
Veröffentlicht in Gynecol Oncol (2019)

Predictive Modeling for Determination of Microscopic Residual Disease at Primary Cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

von Horowitz, Neil S., Maxwell, G. Larry, Miller, Austin, Hamilton, Chad A., Rungruang, Bunja, Rodriguez, Noah, Richard, Scott D., Krivak, Thomas C., Fowler, Jeffrey M., Mutch, David G., Van Le, Linda, Lee, Roger B., Argenta, Peter, Bender, David, Tewari, Krishnansu S., Gershenson, David, Java, James J., Bookman, Michael A.
Veröffentlicht in Gynecol Oncol (2017)

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma

von Rose, Peter G, Java, James J, Salani, Ritu, Geller, Melissa A, Alvarez, Angeles, Tewari, Krishnansu S, Bender, David P, Mutch, David G, Friedlander, Michael L, Van Le, Linda, Method, Michael W, Hamilton, Chad A, Lee, Roger B, Wenham, Robert M, Guntupalli, Saketh R, Markman, Maurie, Muggia, Franco M, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Copeland, Larry J
Veröffentlicht in Obstet Gynecol (2019)